ELV · Elevance Health, Inc.
$418.72
+0.52% last session
End-of-day data · close of 2026-09-11
Market cap
$91B
Enterprise value
$84B
Trailing P/E
18.5
Forward P/E
14.1
Dividend yield
2.0%
Beta
0.70
Avg volume
1M
Employees
96K
Daily Change %
0.52%
5 Days Change
2.66%
10 Days Change
3.80%
30 Days Change
4.81%
60 Days Change
-1.60%
Month to Day Change
3.80%
Year to Day Change
20.57%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ELV
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-17
Latest call per bank · past 12 months
RBC Capital
Sector Perform$424
+1.8% vs priceWells Fargo
Overweight$473
+13.6% vs priceBarclays
Overweight$457
+9.7% vs priceJP Morgan
Overweight$476
+14.3% vs priceBank of America
Buy$460
+10.4% vs priceMorgan Stanley
Equal-Weight$404
-3.0% vs priceUBS
Buy$460
+10.4% vs priceDeutsche Bank
Buy$498
+19.6% vs priceJefferies
Buy$391
-6.1% vs priceGoldman Sachs
Neutral$343
-17.7% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-17 | Leerink Partners | Maintains | Market Perform | $364 → $395 |
| 2026-07-16 | RBC Capital | Maintains | Sector Perform | $439 → $424 |
| 2026-07-16 | Wells Fargo | Maintains | Overweight | $492 → $473 |
| 2026-07-16 | Guggenheim | Maintains | Buy | $399 → $455 |
| 2026-07-16 | Barclays | Maintains | Overweight | $480 → $457 |
| 2026-07-16 | Baird | Maintains | Neutral | $331 → $393 |
| 2026-07-14 | TD Cowen | Maintains | Buy | $400 → $465 |
| 2026-07-14 | Truist Securities | Maintains | Buy | $450 → $475 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 62 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 5.8% above the 50-day MA ($395.60).
- Price vs 200-day MA: Trading 17.0% above the 200-day MA ($357.77).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+1.57) — short-term momentum is improving.
- 52-week range: Price is within 5% of the 52-week high ($424.94).
ELV Price Chart
Loading chart for ELV…
Fundamentals
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
More in Healthcare Plans
UNH
UnitedHealth Group Incorporated
$340B 19.2% YTD
CVS
CVS Health Corporation
$121B 22.9% YTD
CI
The Cigna Group
$74B 3.8% YTD
HUM
Humana Inc.
$49B 57.6% YTD
CNC
Centene Corporation
$33B 58.9% YTD
MOH
Molina Healthcare Inc
$11B 15.4% YTD
OSCR
Oscar Health, Inc.
$10B 126.7% YTD
ALHC
Alignment Healthcare, Inc.
$3B -35.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.